Maulden, United Kingdom

George Stuart Cockerill

USPTO Granted Patents = 21 

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 627(Granted Patents)


Location History:

  • Berkhamsted, Herts, HP4 2DY, GB (1992)
  • Herts, GB (2002)
  • Maulden, GB (2005 - 2009)
  • Bedford, GB (2001 - 2013)
  • Stevenage, GB (2001 - 2023)

Company Filing History:


Years Active: 1992-2025

Loading Chart...
21 patents (USPTO):Explore Patents

Title: The Innovations of George Stuart Cockerill

Introduction

George Stuart Cockerill, a notable inventor based in Maulden, Great Britain, has contributed significantly to the field of pharmaceuticals with a remarkable portfolio of 19 patents. His innovative work primarily focuses on the development of novel pharmaceutical compounds, particularly benzodiazepine derivatives, which have crucial implications in treating respiratory syncytial virus (RSV).

Latest Patents

Cockerill's latest patents include unique formulations of pharmaceutical compounds with benzodiazepine derivatives characterized by complex chemical structures. Specifically, these patents involve formulas where certain variables denote various groups and functionalities that allow the compounds to act as inhibitors of RSV. The patents detail the chemical compositions and their potential therapeutic uses for preventing and treating RSV infections, showcasing Cockerill's dedication to advancing medical science.

Career Highlights

Throughout his career, George Stuart Cockerill has made significant strides in the pharmaceutical industry. He has worked with prominent companies such as SmithKline Beecham Corporation and Glaxo Wellcome Inc., where he honed his skills in drug discovery and development. His contributions in these roles have not only advanced his career but have also led to innovations critical in pharmaceutical science.

Collaborations

Cockerill has collaborated with several distinguished professionals in the field. Notable among them are Malcolm Clive Carter and Karen Elizabeth Lackey. These partnerships have fostered a creative environment conducive to innovation, as they collectively work towards advancing medical treatments through their combined expertise.

Conclusion

George Stuart Cockerill stands out as a prominent inventor in the pharmaceutical landscape. With 19 patents to his name, his work on benzodiazepine derivatives contributes to significant advancements in treating RSV infections. His career, marked by collaborations with leading companies and professionals, reflects his commitment to innovation and the betterment of public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…